What is Blueprint's NAICS code?

Blueprint's NAICS code is 531 (Real Estate).

Insights

Gathering insights about Blueprint…

Similar companies to Blueprint

Blueprint Tech Stack

Blueprint uses 8 technology products and services including MySQL, oEmbed, jQuery Migrate, and more. Explore Blueprint's tech stack below.

MySQL
Database
oEmbed
Dev Tools
jQuery Migrate
Javascript Libraries
Yoast SEO
Search Engines
reCAPTCHA
Security
Google Tag Manager
Tag Management
Genesis Framework
Web Platform Extensions
jQuery Waypoints
Web Tools And Plugins

Media & News

Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) and its transaction with Sanofi. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Blueprint insiders received substantial benefits as part of change of control arrangements and certain insiders may have had conflicts of interests. We are investigating whe.
Aug 27, 2025 | www.businesswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)
NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Blueprint Medicines Corporation (NASDAQ: BPMC ) related to its sale to Sanofi, S.A. Under the terms of the proposed transaction, Sanofi will pay $129.00 per share in cash at closing, and Blueprint shareholders also will receive one non-tradeable contingent value right (“CVR”) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. Is it a fair deal?
Jul 14, 2025 | www.globenewswire.com
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Blueprint Medicines Corporation (NasdaqGS: BPMC) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Blueprint will receive $129.00 per share in cash at closing, and also will receive one non-tradeable contingent value right (CVR) entitling the holder to receive t.
Jun 20, 2025 | www.businesswire.com
HAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Blueprint Medicines Corporation (NASDAQ: BPMC)
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Blueprint Medicines Corporation (NASDAQ: BPMC ) related to it sale to Sanofi. Under the terms of the proposed transaction, Sanofi will pay $129.00 per share in cash at closing, and Blueprint shareholders also will receive one non-tradeable contingent value right (CVR) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. Is it a fair deal?
Jun 15, 2025 | www.globenewswire.com
Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses
-- Breadth of presentations, including one oral and two flash talks, showcase Blueprint Medicines' leadership role in advancing care for patients with systemic mastocytosis -- CAMBRIDGE, Mass. , June 12, 2025 /PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC) today announced data presentations reflecting over a decade of collaboration with clinical experts and patient advocates to transform the treatment of systemic mastocytosis (SM).
Jun 12, 2025 | www.prnewswire.com
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Blueprint Medicines Corporation (NasdaqGS: BPMC) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Blueprint will receive $129.00 per share in cash at closing, and also will receive one non-tradeable contingent value right (CVR) entitling the holder to rece.
Jun 03, 2025 | www.businesswire.com
Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz
Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the impact of tariffs on pharmaceuticals and how to trade in the sector.
Jun 02, 2025 | www.youtube.com

Blueprint's Email Address Formats

Blueprint uses at least 2 format(s):

Blueprint Email Formats	Example	Percentage
First@pacificcharter.org	John@pacificcharter.org	77%
FLast@pacificcharter.org	JDoe@pacificcharter.org	16%
Last@pacificcharter.org	Doe@pacificcharter.org	5%
First.Last@pacificcharter.org	John.Doe@pacificcharter.org	2%

Frequently Asked Questions

Where is Blueprint's headquarters located?

Blueprint's main headquarters is located at 600 Wilshire Boulevard Suite 200 Los Angeles, California 90017 United States. The company has employees across 1 continents, including North America.

What is Blueprint's phone number?

You can contact Blueprint's main corporate office by phone at

+1-213-542-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Blueprint's stock symbol?

Blueprint is a publicly traded company; the company's stock symbol is BPMC.

What is Blueprint's official website and social media links?

Blueprint's official website is blueprintfutures.org and has social profiles on LinkedIn.

What is Blueprint's SIC code NAICS code?

Blueprint's SIC code is 8641 - Civic, Social, and Fraternal Associations NAICS code is 531 - Real Estate.

How many employees does Blueprint have currently?

As of May 2026, Blueprint has approximately 41 employees across 1 continents, including North America. Key team members include Vice President Development: K. H.President And Chief Executive Officer: J. S.Partner: J. L.. Explore Blueprint's employee directory with LeadIQ.

What industry does Blueprint belong to?

Blueprint operates in the Real Estate industry.

What technology does Blueprint use?

Blueprint's tech stack includes MySQLoEmbedjQuery MigrateYoast SEOreCAPTCHAGoogle Tag ManagerGenesis FrameworkjQuery Waypoints.

What is Blueprint's email format?

Blueprint's email format typically follows the pattern of First@pacificcharter.org. Find more Blueprint email formats with LeadIQ.

When was Blueprint founded?

Blueprint was founded in 2004.

Blueprint

Q: What is Blueprint's official website and social media links?

Blueprint's official website is blueprintfutures.org. Blueprint has social profiles on LinkedIn.

Q: How many employees does Blueprint have currently?

Blueprint has approximately 41 employees.

Q: What technology does Blueprint use?

Blueprint's tech stack includes Yoast SEO, Amazon ALB, Google Analytics, Priority Hints, Microsoft 365.

Real EstateCalifornia, United States11-50 Employees

Blueprint is a nonprofit, full-service real estate development firm that partners with charter schools to navigate the complex facilities development process. It coordinates and manages all phases of a facilities project—from site search and design to construction and financing—providing comprehensive support through the entire lifecycle. 

The organization also delivers strategic facilities planning services, working with partners to align current and future facility needs with growth plans. By proactively identifying obstacles, Blueprint seeks creative solutions to help charter schools pursue their long-term facility goals. Based in Los Angeles, California, the firm operates as a small to mid-sized nonprofit within the real estate development sector, specifically focused on charter school facilities.

Company Overview

Headquarters: 600 Wilshire Boulevard Suite 200 Los Angeles, California 90017 United States
Phone number: +1-213-542-****
Website: blueprintfutures.org
SIC Code: 8641 - Civic, Social, and Fraternal Associations
Stock Symbol: BPMC
NAICS Code: 531 - Real Estate
Founded: 2004
Employees: 11-50

Media & News

Funding & Financials

$50M$100M
Blueprint's revenue is estimated to be in the range of $50M$100M

Funding & Financials

$50M$100M
Blueprint's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Blueprint

Success Academy Charter Schools

Achievement First

Aspire Public Schools

Building Hope

Green Dot Public Schools California

Uncommon Schools

Alliance College-Ready Public Schools

Blueprint Tech Stack

Media & News

Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

HAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Blueprint Medicines Corporation (NASDAQ: BPMC)

Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

Blueprint's Email Address Formats

Frequently Asked Questions

Where is Blueprint's headquarters located?

What is Blueprint's phone number?

What is Blueprint's stock symbol?

What is Blueprint's official website and social media links?

What is Blueprint's SIC code NAICS code?

How many employees does Blueprint have currently?

What industry does Blueprint belong to?

What technology does Blueprint use?

What is Blueprint's email format?

When was Blueprint founded?

Blueprint

Company Overview

Media & News

Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?